You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Thyrotropin Releasing Hormone

Showing 1 - 25 of 6,270
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thyroid Cancer Trial in New York (Thyrotropin Releasing Hormone (TRH), levothyroxine, Hypothyroidism QOL questionnaire)

Recruiting
  • Thyroid Cancer
  • Thyrotropin Releasing Hormone (TRH)
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 12, 2022

Subclinical Hypothyroidism Trial in Philadelphia (Levothyroxine, Liothyronine, Thyrotropin-Releasing Hormone)

Completed
Has Results
  • Subclinical Hypothyroidism
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Feb 16, 2021

Central Precocious Puberty Trial (Debio 4326)

Not yet recruiting
  • Central Precocious Puberty
  • Debio 4326
  • (no location specified)
Nov 8, 2023

Intracytoplasmic Sperm Injection, GnRH Agonist, Infertility Trial (ultrashort GnRHa, short GnRHa, long GnRHa)

Not yet recruiting
  • Intracytoplasmic Sperm Injection
  • +3 more
  • ultrashort GnRHa
  • +2 more
  • (no location specified)
Oct 2, 2022

Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage IIC Prostate Cancer AJCC v8 Trial in Houston (drug,

Completed
Has Results
  • Prostate Adenocarcinoma
  • +4 more
  • Abiraterone Acetate
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

Reproductive Disorder Trial in Boston (kisspeptin 112-121, GnRH)

Enrolling by invitation
  • Reproductive Disorder
  • kisspeptin 112-121
  • GnRH
  • Boston, Massachusetts
    Massachusetts General Hospital
Jun 12, 2023

Prostatic Tumors Trial in Bronx (Abiraterone Acetate, Prednisone)

Active, not recruiting
  • Prostatic Neoplasms
  • Bronx, New York
    Montefiore Medical Center
Sep 22, 2022

Ovary Cyst, Fertility Issues Trial in Zagazig (progestin primed ovarian stimulation protocol, dydrogesterone (Duphaston,

Recruiting
  • Ovary Cyst
  • Fertility Issues
  • progestin primed ovarian stimulation protocol
  • +2 more
  • Zagazig, Egypt
    Zagazig University
Mar 1, 2023

Cushing's Disease, Pituitary Adenoma Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Acthrel)

Not yet recruiting
  • Cushing's Disease
  • Pituitary Adenoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Gonadotropin-releasing Hormone Agonist in Ovarian Preservation

Recruiting
  • Systemic Lupus Erythematosus (Sle)
  • Primary Ovarian Insufficiency (Poi)
    • Bethesda, Maryland
      National Institute of Arthritis and Musculoskeletal and Skin Dis
    Feb 2, 2023

    Kallmann Syndrome, Idiopathic Hypogonadotropic Hypogonadism, GnRH Deficiency Trial in Boston (gonadotropin releasing hormone

    Completed
    • Kallmann Syndrome
    • +2 more
    • gonadotropin releasing hormone (GnRH)
    • Boston, Massachusetts
      Massachusetts General Hospital
    Jun 29, 2022

    Female Infertility Trial in Alexandria (gonadotropin releasing hormone-agonist, Progesterone)

    Recruiting
    • Female Infertility
    • Alexandria, Egypt
      Alexandria University
    Apr 5, 2022

    Prostate Cancer, Bone Metastases Trial in Brescia (Zoledronic Acid, Enzalutamide)

    Recruiting
    • Prostate Cancer
    • Bone Metastases
    • Brescia, Italy
      Azienda Ospedaliera Spedali Civili di Brescia
    Mar 4, 2022

    Infertility Trial in Krasnodar (Gonadotropin-releasing hormone agonist)

    Active, not recruiting
    • Infertility
    • Gonadotropin-releasing hormone agonist
    • Krasnodar, Krasnodar Krai, Russian Federation
      Alisa Baklakova
    Nov 20, 2021

    Growth Hormone Deficiency Trial in New York (Blood draws, Growth hormone releasing hormone (GHRH) and arginine, Carotid

    Terminated
    Has Results
    • Growth Hormone Deficiency
    • Blood draws
    • +4 more
    • New York, New York
      Columbia University, College of Physicians and Surgeons
    Oct 24, 2022

    Reproductive Disorder, PCOS, Polycystic Ovary Syndrome Trial in Boston (kisspeptin 112-121, GnRH)

    Not yet recruiting
    • Reproductive Disorder
    • +2 more
    • kisspeptin 112-121
    • GnRH
    • Boston, Massachusetts
      Massachusetts General Hospital
    Jul 31, 2023

    Infertility Trial in Xi'an (Biosimilar cetrorelix acetate, Reference cetrorelix acetate)

    Not yet recruiting
    • Infertility
    • Biosimilar cetrorelix acetate
    • Reference cetrorelix acetate
    • Xi'an, None Selected, China
      He Cai
    Sep 7, 2023

    Submucous Leiomyoma of Uterus Trial in Hangzhou (Zoladex, Mifepristone Oral Tablet)

    Not yet recruiting
    • Submucous Leiomyoma of Uterus
    • Hangzhou, Zhejiang, China
      Women's Hospital School of Medicine Zhejiang University
    Jun 7, 2023

    Endometrial Tumor Malignant Stage I Trial in Shanghai (Megestrol Acetate 160 MG Oral Tablet, Medroxyprogesterone Acetate 500 MG,

    Recruiting
    • Endometrial Neoplasm Malignant Stage I
    • Megestrol Acetate 160 MG Oral Tablet
    • +3 more
    • Shanghai, Shanghai, China, China
      Obstetrics and Gynecology Hospital, Fudan University
    Mar 25, 2022

    Prostate Cancer Metastatic, Radiation Therapy, Positron-Emission Tomography Trial in Umeå, Jönköping (stereotactic body

    Recruiting
    • Prostate Cancer Metastatic
    • +2 more
    • stereotactic body radiotherapy
    • +2 more
    • Umeå, Umea, Sweden
    • +1 more
    May 19, 2022

    Breast Cancer Trial in Rome (Acupuncture)

    Recruiting
    • Breast Cancer
    • Acupuncture
    • Rome, Italy
      Fondazione Policlinico Gemelli- IRCCS
    Feb 27, 2023

    (Dyadic Adjustment) on Quality of Life of Prostate Cancer With

    Completed
    • Prostate Cancer
    • Gonadotropin-releasing Hormone (GnRH) agonist therapy
    • Paris, France
      Ipsen Central Contact
    Dec 3, 2021

    Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian

    Not yet recruiting
    • Hormone-receptor-positive Breast Cancer
    • +3 more
    • Aromatase inhibitor
    • +3 more
    • Guangzhou, Guangdong, China
      Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
    Apr 5, 2023

    Diminished Ovarian Reserve Trial (Dydrogesterone priming ovarian stiumulation protocol, GnRH antagonist protocol)

    Not yet recruiting
    • Diminished Ovarian Reserve
    • Dydrogesterone priming ovarian stiumulation protocol
    • GnRH antagonist protocol
    • (no location specified)
    Apr 26, 2023

    Prostate Cancer With =10 Bone Metastases Trial (Apalutamide, 89Sr, Luteinizing Hormone-Releasing Hormone Analog)

    Not yet recruiting
    • Prostate Cancer With ≤10 Bone Metastases
    • (no location specified)
    Feb 22, 2023